Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-090874
Filing Date
2023-04-04
Accepted
2023-04-04 16:16:21
Documents
19

Document Format Files

Seq Description Document Type Size
1 DEF 14A d344283ddef14a.htm   iXBRL DEF 14A 605618
6 GRAPHIC g344283g02g01.jpg GRAPHIC 49028
7 GRAPHIC g344283g02g02.jpg GRAPHIC 22072
8 GRAPHIC g344283g04g51.jpg GRAPHIC 22567
9 GRAPHIC g344283g45g00.jpg GRAPHIC 68328
10 GRAPHIC g344283gra0064.jpg GRAPHIC 3256
  Complete submission text file 0001193125-23-090874.txt   1552242

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA xoma-20221231.xsd EX-101.SCH 5267
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xoma-20221231_def.xml EX-101.DEF 5155
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE xoma-20221231_lab.xml EX-101.LAB 7480
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xoma-20221231_pre.xml EX-101.PRE 4577
13 EXTRACTED XBRL INSTANCE DOCUMENT d344283ddef14a_htm.xml XML 146191
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

EIN.: 522154066 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39801 | Film No.: 23797684
SIC: 2834 Pharmaceutical Preparations